Champions Oncology CSBR
NASDAQ CSBR
$4.79 -0.11 (-2.24%)
As of: Oct 14, 2026 · 1:42 PM EDT

Champions Oncology (CSBR) Income from Non-Controlling Interests (2025)

Updated

Champions Oncology (CSBR) reported Income from Non-Controlling Interests of -$31,000 for fiscal Q2 2026 (quarter ended Oct 31, 2025).

Analysis

Champions Oncology (CSBR) Income from Non-Controlling Interests (2025) Analysis & Trends

Over the twelve months ended Oct 31, 2025, Champions Oncology's Income from Non-Controlling Interests came in at -$61,000.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Inc. Minority (Qtr)
1 Iqvia Holdings 43.58 Bn 35.29 Bn 1.44 Bn 2.00 Mn
2 Medpace Holdings 17.39 Bn 15.45 Bn 201.64 Mn -
3 Charles River Laboratories International 14.53 Bn 13.73 Bn 363.37 Mn 722,000.00
4 Icon 13.23 Bn 10.34 Bn 479.29 Mn -
5 Fortrea Holdings 2.01 Bn 1.39 Bn 139.20 Mn -
6 Ginkgo Bioworks Holdings 712.22 Mn -49.86 Mn 18.44 Mn -
7 Evotec SE 502.55 Mn -1.11 Bn - -
8 Champions Oncology 66.57 Mn 41.65 Mn 7.70 Mn -
9 MindWalk Holdings 64.01 Mn 27.66 Mn 1.61 Mn -
10 Natural Alternatives International 6.63 Mn -21.45 Mn 1.73 Mn -
Historic Data

Historic Data

Download Data
DateValue
Oct 31, 2025 -31,000.00
Jul 31, 2025 -30,000.00
API Access

Champions Oncology Income from Non-Controlling Interests API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=income-from-non-controlling-interests&ticker=CSBR&period=max&api_key=YOUR_API_KEY